gabapentin has been researched along with Burning Mouth Syndrome in 10 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Burning Mouth Syndrome: A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Burning mouth syndrome is a debilitating disorder involving oral pain that may have at least 4 underlying causes." | 5.32 | Effectiveness of gabapentin for treatment of burning mouth syndrome. ( Emko, P; Kent, PF; Kurtz, DB; White, TL, 2004) |
| "Gabapentin was seen in one study to work alone and synergistically with ALA." | 2.58 | Burning mouth syndrome: a systematic review of treatments. ( Han, P; Inman, JC; Kim, Y; Liu, YF; Yoo, T, 2018) |
| "Clonazepam was administered as the first-line medication." | 1.62 | Treatment outcomes and related clinical characteristics in patients with burning mouth syndrome. ( Kho, HS; Kim, J; Kim, MJ, 2021) |
| "Burning mouth syndrome is a debilitating disorder involving oral pain that may have at least 4 underlying causes." | 1.32 | Effectiveness of gabapentin for treatment of burning mouth syndrome. ( Emko, P; Kent, PF; Kurtz, DB; White, TL, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, MJ | 1 |
| Kim, J | 1 |
| Kho, HS | 1 |
| Oberoi-Jassal, R | 1 |
| Portman, D | 1 |
| Smith, J | 1 |
| Rajasekhara, S | 1 |
| Desai, VV | 1 |
| Donovan, KA | 1 |
| Chang, YD | 1 |
| Liu, YF | 1 |
| Kim, Y | 1 |
| Yoo, T | 1 |
| Han, P | 1 |
| Inman, JC | 1 |
| Pigatto, PD | 1 |
| Guzzi, G | 1 |
| López-D'alessandro, E | 1 |
| Escovich, L | 1 |
| Martin, WJ | 1 |
| Forouzanfar, T | 1 |
| Gerlinger, I | 1 |
| White, TL | 1 |
| Kent, PF | 1 |
| Kurtz, DB | 1 |
| Emko, P | 1 |
| Heckmann, SM | 1 |
| Heckmann, JG | 1 |
| Ungethüm, A | 1 |
| Hujoel, P | 1 |
| Hummel, T | 1 |
| Scardina, GA | 1 |
| Pisano, T | 1 |
| Messina, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Study on the Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine(TCM) and Western Medicine Based on TCM Syndrome Differentiation[NCT04189367] | Phase 3 | 80 participants (Anticipated) | Interventional | 2020-06-20 | Not yet recruiting | ||
| Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction[NCT05184192] | Phase 2 | 50 participants (Anticipated) | Interventional | 2022-01-10 | Enrolling by invitation | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for gabapentin and Burning Mouth Syndrome
| Article | Year |
|---|---|
Burning mouth syndrome: a systematic review of treatments.
Topics: Amines; Analgesics; Antioxidants; Burning Mouth Syndrome; Capsaicin; Clonazepam; Cyclohexanecarboxyl | 2018 |
The efficacy of anticonvulsants on orofacial pain: a systematic review.
Topics: Amines; Anticonvulsants; Burning Mouth Syndrome; Carbamazepine; Clonazepam; Cyclohexanecarboxylic Ac | 2011 |
[Burning sensation in oral cavity--burning mouth syndrome in everyday medical practice].
Topics: Acetamides; Amines; Anti-Anxiety Agents; Antidepressive Agents; Antioxidants; Burning Mouth Syndrome | 2012 |
[Burning mouth syndrome].
Topics: Age Factors; Aged; Amines; Analgesics; Anti-Anxiety Agents; Antioxidants; Burning Mouth Syndrome; Cl | 2007 |
1 trial available for gabapentin and Burning Mouth Syndrome
| Article | Year |
|---|---|
Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial.
Topics: Amines; Burning Mouth Syndrome; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Double-Blind | 2011 |
5 other studies available for gabapentin and Burning Mouth Syndrome
| Article | Year |
|---|---|
Treatment outcomes and related clinical characteristics in patients with burning mouth syndrome.
Topics: Burning Mouth Syndrome; Clonazepam; Gabapentin; Humans; Retrospective Studies; Treatment Outcome | 2021 |
Burning Mouth Pain: A Case Report.
Topics: Analgesics; Burning Mouth Syndrome; Carcinoma, Squamous Cell; Clonazepam; Female; Fentanyl; Gabapent | 2018 |
Neuropathic pain in children after exposure to mercury.
Topics: Amines; Analgesics, Non-Narcotic; Burning Mouth Syndrome; Child; Cyclohexanecarboxylic Acids; Gabape | 2008 |
Effectiveness of gabapentin for treatment of burning mouth syndrome.
Topics: Acetates; Aged; Amines; Burning Mouth Syndrome; Cyclohexanecarboxylic Acids; Female; GABA Agonists; | 2004 |
Gabapentin has little or no effect in the treatment of burning mouth syndrome - results of an open-label pilot study.
Topics: Aged; Amines; Burning Mouth Syndrome; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Female; | 2006 |